Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response
Article in BJC Reports (June 2024)
The most recent citing publications are shown below. View all 71 publications that cite this research output on Dimensions.
Article in BJC Reports (June 2024)
Article in Journal of Clinical Pathology (January 2024)
Article in iScience (January 2024)